VIRIOS THERAPEUTICS INC (VIRI)       0.3566  +0.02 (+6.42%)

Virios Therapeutics Announces Scheduling of FDA Meeting in March 2023 to Discuss IMC-1 Fibromyalgia Phase 3 Program

ATLANTA, Jan. 05, 2023 (GLOBE NEWSWIRE) --  Virios Therapeutics, Inc. (Nasdaq: VIRI), a development-stage biotechnology company focused on advancing...

Virios Therapeutics, Inc. to Present at the Virtual Planet MicroCap Showcase

Virios Therapeutics Announces Third Quarter 2022 Financial Results and Provides Corporate Update

Virios Therapeutics to Report Third Quarter 2022 Financial Results and Provide Corporate Update on Monday, November 14, 2022

Virios Therapeutics, Inc. Announces Closing of Public Offering

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

It's time for an overview of the biggest pre-market stock movers for Thursday and all the news behind this morning's movement.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

Good morning, investor! It's time to start the day with a breakdown of the biggest pre-market stock movers for Tuesday morning!

Virios Therapeutics, Inc. Announces Pricing of Public Offering

Virios Therapeutics, Inc. Announces Proposed Public Offering